MoneyWorks4Me

The sales figure stood at Rs. 1568.22 millions for the March 2026 quarter. The mentioned figure indicates a growth of about 35.57% as compared to Rs. 1156.76 millions during the year-ago period.Profit for the quarter ended March 2026 rises by 74.43% to Rs. 252.90  millions from Rs. 144.99 millions.Operating profit for the quarter ended March 2026 rose to 397.96 millions as compared to 266.64 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1568.22 1156.76 35.57 5030.59 3701.97 35.89 5030.59 3701.97 35.89
Other Income 10.58 7.65 38.30 28.59 19.20 48.91 28.59 19.20 48.91
PBIDT 397.96 266.64 49.25 1210.88 823.64 47.02 1210.88 823.64 47.02
Interest 28.87 24.92 15.85 109.70 98.78 11.05 109.70 98.78 11.05
PBDT 369.09 241.72 52.69 1092.89 724.86 50.77 1092.89 724.86 50.77
Depreciation 52.61 50.79 3.58 197.94 182.58 8.41 197.94 182.58 8.41
PBT 316.48 190.93 65.76 894.95 542.28 65.03 894.95 542.28 65.03
TAX 63.58 45.94 38.40 221.46 143.38 54.46 221.46 143.38 54.46
Deferred Tax -18.46 -15.87 16.32 -8.87 -15.89 -44.18 -8.87 -15.89 -44.18
PAT 252.90 144.99 74.43 673.49 398.90 68.84 673.49 398.90 68.84
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 25.38 23.05 10.09 24.07 22.25 8.19 24.07 22.25 8.19
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..